Literature DB >> 10879286

Strategies for immunotherapy of cancer.

C J Melief1, R E Toes, J P Medema, S H van der Burg, F Ossendorp, R Offringa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10879286     DOI： 10.1016/s0065-2776(00)75006-1

Source DB:  PubMed          Journal:  Adv Immunol        ISSN： 0065-2776            Impact factor:   3.543


× No keyword cloud information.
  31 in total

Review 1.  Rational design of peptide-based tumor vaccines.

Authors:  Wilson S Meng; Lisa H Butterfield
Journal:  Pharm Res       Date:  2002-07       Impact factor: 4.200

Review 2.  Modulation of antitumor responses by dendritic cells.

Authors:  Johannes Vieweg; Andrew Jackson
Journal:  Springer Semin Immunopathol       Date:  2005-01

3.  Salmonella pathogenicity island 2-mediated overexpression of chimeric SspH2 proteins for simultaneous induction of antigen-specific CD4 and CD8 T cells.

Authors:  Klaus Panthel; Katrin M Meinel; Victòria E Sevil Domènech; Heike Retzbach; Emeka I Igwe; Wolf-Dietrich Hardt; Holger Rüssmann
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

4.  Redirection of T cells by delivering a transgenic mouse-derived MDM2 tumor antigen-specific TCR and its humanized derivative is governed by the CD8 coreceptor and affects natural human TCR expression.

Authors:  Ralf-Holger Voss; Jürgen Kuball; Renate Engel; Philippe Guillaume; Pedro Romero; Christoph Huber; Matthias Theobald
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

5.  4-1BB regulates NKG2D costimulation in human cord blood CD8+ T cells.

Authors:  Young-June Kim; Myung-Kwan Han; Hal E Broxmeyer
Journal:  Blood       Date:  2007-11-16       Impact factor: 22.113

6.  Antitumor activity of human γδ T cells transducted with CD8 and with T-cell receptors of tumor-specific cytotoxic T lymphocytes.

Authors:  Takeshi Hanagiri; Yoshiki Shigematsu; Koji Kuroda; Tetsuro Baba; Hironobu Shiota; Yoshinobu Ichiki; Yoshika Nagata; Manabu Yasuda; Tomoko So; Mitsuhiro Takenoyama; Fumihiro Tanaka
Journal:  Cancer Sci       Date:  2012-07-06       Impact factor: 6.716

7.  T cells and stromal fibroblasts in human tumor microenvironments represent potential therapeutic targets.

Authors:  Jennifer L Barnas; Michelle R Simpson-Abelson; Sandra J Yokota; Raymond J Kelleher; Richard B Bankert
Journal:  Cancer Microenviron       Date:  2010-03-31

8.  Immunological factors relating to the antitumor effect of temozolomide chemoimmunotherapy in a murine glioma model.

Authors:  Tai-Gyu Kim; Chang-Hyun Kim; Jung-Sun Park; Sung-Dong Park; Chung Kwon Kim; Dong-Sup Chung; Yong-Kil Hong
Journal:  Clin Vaccine Immunol       Date:  2009-11-04

9.  Human follicular lymphoma CD39+-infiltrating T cells contribute to adenosine-mediated T cell hyporesponsiveness.

Authors:  Shannon P Hilchey; James J Kobie; Mathew R Cochran; Shelley Secor-Socha; Jyh-Chiang E Wang; Ollivier Hyrien; W Richard Burack; Tim R Mosmann; Sally A Quataert; Steven H Bernstein
Journal:  J Immunol       Date:  2009-10-28       Impact factor: 5.422

10.  Effect of B7.1 costimulation on T-cell based immunity against TAP-negative cancer can be facilitated by TAP1 expression.

Authors:  Xiao-Lin Li; Yong-Yu Liu; David Knight; Yoshinobu Odaka; J Michael Mathis; Runhua Shi; Jonathan Glass; Qian-Jin Zhang
Journal:  PLoS One       Date:  2009-07-24       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.